NEWYou can now listen to Fox News articles! As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray-market” GLP-1s (such as semaglutide or tirzepatide) …
Read More »
NEWYou can now listen to Fox News articles! As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as semaglutide or …
Read More »
NEWYou can now listen to Fox News articles! An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating two hunger hormones — amylin, which regulates appetite and creates a feeling of fullness, and glucagon-like peptide 1 (GLP-1), the …
Read More »
NEWYou can now listen to Fox News articles! A 66-year-old grandfather who exercised daily was stunned to learn he was pre-diabetic — and he says making one small change to his eating habits helped reverse it. Dance teacher Will McKechnie, from Lytham St Annes, Lancashire, told SWNS he had always considered himself healthy. At 5 feet 10 inches tall and 167 …
Read More »
NEWYou can now listen to Fox News articles! Your genetic makeup could be the reason you’re not losing weight. New research from Harvard T.H. Chan School of Public Health and Ben Gurion University in Israel found that one-third of people who followed a healthy diet did not lose any weight — although they did experience health benefits. Participants exhibited “significant …
Read More »
NEWYou can now listen to Fox News articles! Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro). The finding comes from a recent study presented this week at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting …
Read More »
NEWYou can now listen to Fox News articles! A popular diet trend may have its origins in the Bible. Intermittent fasting, a pattern of eating based on time limits, is intended to assist with weight loss and other health benefits, according to Mayo Clinic. There are several types of intermittent fasting, but they all follow the same concept of alternating …
Read More »
NEWYou can now listen to Fox News articles! Side effects from GLP-1s can vary — but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New …
Read More »
NEWYou can now listen to Fox News articles! Embarking on a low-calorie diet could potentially lead to negative mental health, researchers in Toronto, Canada, have revealed. A new study, published in BMJ Nutrition, Prevention and Health, investigated how the adoption of restrictive diets could instigate depressive symptoms. Using the National Health and Nutrition Examination Survey, researchers analyzed nearly 29,000 adults …
Read More »
NEWYou can now listen to Fox News articles! Weight-loss drugs continue to grow in popularity, with market researchers predicting that global demand for the medications could reach $150 billion by 2035. GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — are intended to treat type 2 diabetes and obesity. Recent studies, however, have …
Read More »
tvt news Haberler